Cost-effectiveness analysis of imaging surveillance in stage II and III extremity soft tissue sarcoma: an Australian perspective.
Susie BaeJonathan KarnonGlenis CraneTaryn BessenJayesh DesaiPhillip CroweSusan NeuhausPublished in: Cost effectiveness and resource allocation : C/E (2020)
Wide variations were observed in surveillance imaging practices in this high-risk STS cohort. Modelling demonstrated the value of CT chest for distant recurrence surveillance over other forms of imaging in terms of cost and QALYs. Further work is required to evaluate cost-effectiveness in a prospective manner.